(Reuters) – The U.S. healthcare system is more effective at delivering high costs than quality care, according to a new study that found first-rate treatment for cancer but insufficient primary care for other ailments.
The study, released on Wednesday by the 34-nation Organization for Economic Cooperation and Development, or OECD, said Americans pay more than $7,900 per person for healthcare each year — far more than any other OECD country — but still die earlier than their peers in the industrialized world.
The cost of healthcare in the United States is 62 percent higher than that in Switzerland, which has a similar per capita income and also relies substantially on private health insurance.
Meanwhile, Americans receive comparatively little actual care, despite sky-high prices driven by expensive tests and procedures. They also spend more tax money on healthcare than most other countries, the study showed.
An “underdeveloped” U.S. primary care system is plagued by shortages of family doctors and high rates of avoidable hospital admissions for people with asthma, lung disease, diabetes, hypertension and other common illnesses.
U.S. survival rates are the world’s highest among breast cancer patients and the second highest, after Japan, for people with colorectal cancer – due in part to effective early screening, the study showed. The study also said Americans experience generally good acute hospital care.
“It’s a very, very mixed pattern,” said Mark Pearson, head of the OECD health division. “You get a very high quality of care for your money in some areas. Very poor quality, compared to other countries, in other areas.”
The quality and cost of the $2.6 trillion U.S. healthcare system are at the forefront of a rancorous national political debate over how to regulate and pay for treatment, particularly for the poor and elderly.
The 2010 U.S. healthcare reform law, which seeks to control costs over time by altering incentives for doctors and other providers, faces a constitutional challenge in the Supreme Court, and Republican presidential candidates on the campaign trail have called for its repeal.
LESS CARE, MORE MONEY
Federal spending on Medicare and Medicaid, the government programs for the elderly and the poor, is also a leading target of efforts to narrow the yawning U.S. fiscal deficit.
The OECD said U.S. public spending on healthcare reached 8 percent of the economy versus a 7 percent OECD average in 2009, the latest year for which comparison figures are available.
A forum of developed nations set up to foster global development, the OECD said U.S. life expectancy of 78.2 years ranked 28th – just behind Chile’s and well below the average of 79.5 years among member nations.
The growth in U.S. life expectancy over the past half century is also below average, gaining only 8.3 years since 1960 compared with an 11.2-year OECD average.
The United States was ranked fourth from the bottom for premature mortality, which focuses on deaths among younger people. The measure, which reflects dangers posed by violence, accidents and environmental hazards, puts America behind all others save Hungary, Mexico and Russia.
Pearson said researchers believe national mortality rates increasingly reflect the quality of healthcare, though more than half of the equation is still believed to lie with other indicators including lifestyle and diet.
Americans have fewer doctors and hospital beds, make fewer doctor visits, go to the hospital less often and stay for shorter lengths of time than about three-quarters of the other OECD countries.
But the United States is at the front of the pack when it comes to costly medical procedures including knee replacements, MRI and CT scans and tonsillectomies.
And it is consistently at the top of the cost chart for a number of procedures including caesarean sections, which are almost twice as expensive in the United States as in Germany.
Pharmaceuticals also cost about 60 percent more than in a range of European countries.
Pearson said one reason prices are higher in the United States is that the healthcare system lacks what other countries have: an effective government mechanism that acts to keep prices down.
“That’s simply not there in the U.S. system. So it’s a structural defect,” he said.
(Editing by Gary
